Page last updated: 2024-08-24

rolofylline and Dyspnea

rolofylline has been researched along with Dyspnea in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albert, NM; Butler, J; Carson, PE; Collins, SP; Colvin-Adams, M; Dimarco, JP; Ezekowitz, JA; Fang, JC; Givertz, MM; Hernandez, AF; Hershberger, RE; Katz, SD; Krishnamani, R; Rogers, JG; Spertus, JA; Starling, RC; Stevenson, WG; Stough, WG; Sweitzer, NK; Tang, WH; Teerlink, JR; Walsh, MN; Westlake Canary, CA1
Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA1
Bloomfield, DM; Cotter, G; Dittrich, HC; Massie, BM; Metra, M; O'Connor, CM; Weatherley, BD1
Cleland, JG; Cotter, G; Dittrich, HC; Givertz, MM; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Voors, AA; Weatherley, BD1
Gheorghiade, M; Ruschitzka, F1
Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; DeLucca, P; Dittrich, H; Givertz, MM; Jia, G; Mansoor, GA; Massie, B; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Voors, AA1

Reviews

1 review(s) available for rolofylline and Dyspnea

ArticleYear
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
    Journal of cardiac failure, 2013, Volume: 19, Issue:6

    Topics: Adrenomedullin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiotonic Agents; Clinical Trials as Topic; Diet, Sodium-Restricted; Diuretics; Dopamine; Dose-Response Relationship, Drug; Dyspnea; Glycopeptides; Heart Failure; Hemofiltration; Hospitalization; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Peptide Fragments; Prognosis; Protein Precursors; Quality of Health Care; Relaxin; Risk Assessment; Saline Solution, Hypertonic; Urea; Vasodilator Agents; Xanthines

2013

Trials

4 trial(s) available for rolofylline and Dyspnea

ArticleYear
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
    European heart journal, 2014, May-14, Volume: 35, Issue:19

    Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Patient Readmission; Renal Insufficiency; Sulfonamides; Torsemide; Treatment Outcome; Weight Loss; Xanthines

2014
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
    Journal of cardiac failure, 2008, Volume: 14, Issue:8

    Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Cardiovascular Agents; Confidence Intervals; Disease Progression; Diuresis; Dyspnea; Female; Heart Failure; Humans; Male; Pilot Projects; Renal Insufficiency; Risk; Risk Factors; Xanthines

2008
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
    European journal of heart failure, 2010, Volume: 12, Issue:5

    Topics: Aged; Diuretics; Dyspnea; Europe; Female; Health Status Indicators; Heart Failure; Hospitalization; Humans; Italy; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Treatment Outcome; Xanthines

2010
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
    European heart journal, 2011, Volume: 32, Issue:12

    Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Prospective Studies; Treatment Outcome; Xanthines

2011

Other Studies

1 other study(ies) available for rolofylline and Dyspnea

ArticleYear
Beyond dyspnoea as an endpoint in acute heart failure trials.
    European heart journal, 2011, Volume: 32, Issue:12

    Topics: Adenosine A1 Receptor Antagonists; Dyspnea; Female; Heart Failure; Humans; Male; Xanthines

2011